EFP
NAUT icon

Elser Financial Planning’s Nautilus Biotechnolgy NAUT Stock Holding History

Elser Financial Planning’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$16.8K – 96
2024
Q4 		$16.8K Buy
+10,000
New +$23.9K ﹤0.01% 110

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Elser Financial Planning's NAUT Position: Q1 2025 in Review

Elser Financial Planning sold out of Nautilus Biotechnolgy (NAUT) in Q1 2025, closing a stake of 10,000 shares — an estimated $16.8K sold.

Elser Financial Planning first reported a position in NAUT in Q4 2024 and held it in 1 quarter. The position peaked at $16.8K in Q4 2024. 88 funds tracked by Wall St. Rank hold NAUT as of Q1 2025.

  • Elser Financial Planning reported no remaining Nautilus Biotechnolgy position as of Q1 2025 after selling out during the quarter.
  • Elser Financial Planning sold 10,000 Nautilus Biotechnolgy shares in Q1 2025, an estimated $16.8K.
  • Elser Financial Planning first reported a position in Nautilus Biotechnolgy in Q4 2024 and held it in 1 quarter.
  • Elser Financial Planning's Nautilus Biotechnolgy position peaked at $16.8K in Q4 2024.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2025.

Based on Elser Financial Planning's 13F filing for Q1 2025, filed 22 Apr 2025.